2025-08-29 00:55:27
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Vivo Bio Tech Ltd consolidated Q3FY22 PAT at Rs. 1.37 crore
Posted On : 2022-02-02 20:27:01( TIMEZONE : IST )
VIVO BIO TECH LTD. has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 12.9202 crores during the period ended December 31, 2021 as compared to Rs. 10.1984 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.3721 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.2771 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.93 for the period ended December 31, 2021 as compared to Rs. 0.19 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 12.9202 crs | ₹10.1984 crs |  26.69% |
| Net Profit | ₹1.3721 crs | ₹0.2771 crs | 395.16% |
| EPS | ₹0.93 | ₹0.19 | 389.47% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 12.9202 crores during the period ended December 31, 2021 as compared to Rs.11.8746 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.3721 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.2.2276 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.93 for the period ended December 31, 2021 as compared to Rs.1.70 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 12.9202 crs | ₹11.8746 crs | 8.81% |
| Net Profit | ₹1.3721 crs | ₹2.2276 crs |  -38.40% |
| EPS | ₹0.93 | ₹1.70 | -45.29% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.36.3365 crores during the 9 Months period ended December 31, 2021 as compared to Rs.35.6939 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.2.8886 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.5.3850 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.1.95 for the 9 Months period ended December 31, 2021 as compared to Rs.4.12 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹36.3365 crs | ₹35.6939 crs | 1.80% |
| Net Profit | ₹2.8886 crs | ₹5.3850 crs | -46.36% |
| EPS | ₹1.95 | ₹4.12 | -52.67% |
Shares of VIVO BIO TECH LTD. was last trading in BSE at Rs. 68.65 as compared to the previous close of Rs. 67.55. The total number of shares traded during the day was 4087 in over 106 trades.
The stock hit an intraday high of Rs. 69.75 and intraday low of 66.50. The net turnover during the day was Rs. 279028.00.
